Device type · QEA
Brain Injury Adjunctive Interpretive Oculomotor Assessment Aid
Last checked: Nov 19, 2026Source: openFDAMethods & limitations
Product code
QEA
Neurology
Device class
Class II
FDA decisions since 2015
7
510(k), De Novo and PMA
Adverse event reports
0
Received Nov 1, 2025 to Nov 19, 2026
How FDA classifies it
- Device type
- Brain Injury Adjunctive Interpretive Oculomotor Assessment Aid
- Product code
- QEA
- Device class
- Class II
- Review panel
- Neurology
- Regulation
- 21 CFR 882.1455
- Specialty
- Neurology & Neurosurgery
- FDA record
- Classification database entry for QEA
Latest FDA decisions
- EyeBOX SNAP510(k)
K254086 · Decided Jun 5, 2026 · 169 days after receipt
Device type: Brain Injury Adjunctive Interpretive Oculomotor Assessment Aid (QEA) · Neurology & Neurosurgery
- EyeBOX EBX-4.1510(k)
K242116 · Decided Apr 4, 2025 · 259 days after receipt
Device type: Brain Injury Adjunctive Interpretive Oculomotor Assessment Aid (QEA) · Neurology & Neurosurgery
- EyeBOX (Model EBX-4)510(k)
K212310 · Decided Dec 22, 2021 · 152 days after receipt
Device type: Brain Injury Adjunctive Interpretive Oculomotor Assessment Aid (QEA) · Neurology & Neurosurgery
4 more FDA decisions with a free account
Reports received
0
Received Nov 1, 2025 to Nov 19, 2026
Malfunction reports
0
Injury reports
0
Death reports
0
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
No reports to chart for this view.
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
No manufacturers to rank.
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
No device problems coded.
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
No patient problems coded.
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-2114-2025 · Started Sep 19, 2023 · Posted by FDA Jul 11, 2025
Reason given: Eye syncing issues causing the device to be inoperable. Unable to be repaired due to discontinuation of support for the Pico 2 platform, which was no longer in production or serviceable as of August 31, 2023.
Cause as FDA categorized it: Device Design
- EyeBOX Model OCL 02Terminated
Z-2398-2019 · Started Apr 16, 2019
Reason given: A review of the user manual revealed that two precaution statements were missing.
Cause as FDA categorized it: Labeling design
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.